Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (62)
  • 2024 (50)
  • 2023 (77)
  • 2022 (95)
  • 2021 (84)
  • 2020 (17)
  • 2019 (21)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Extraditions (50)

Drug Name

  • Oxycodone (75)
  • Fentanyl (65)
  • Opioids (57)
  • Cocaine (26)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Methamphetamine (18)
  • Heroin (14)
  • Benzodiazepines (13)
  • Morphine (10)
  • Amphetamines (9)
  • Methadone (5)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (48)
  • New York (39)
  • St. Louis (39)
  • Seattle (25)
  • Sede (25)
  • New England (24)
  • Miami (22)
  • Atlanta (20)
  • Dallas (19)
  • Chicago (18)
  • San Francisco (18)
  • El Paso (17)
  • New Jersey (17)
  • Houston (16)
  • San Diego (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (8)
  • Rocky Mountain (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

Julio 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
Julio 20, 2022
PRESS RELEASE

East Windsor Man Admits Role In Oxycodone Prescription Fraud Scheme

Julio 19, 2022
EAST WINDSOR, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that an East Windsor man has admitted his role in a scheme to acquire and distribute oxycodone obtained through fraudulent prescriptions. On July 5, 2022, JAYSON KEMP, 45, pleaded guilty before U.S. District...
Julio 19, 2022
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

Julio 19, 2022
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
Julio 19, 2022
PRESS RELEASE

Accused Major Heroin Trafficker Extradited from Colombia for Prosecution in New York City

Julio 18, 2022
NEW YORK - An accused major trafficker was extradited from Colombia to face charges associated with smuggling and selling multi-kilogram quantities of heroin in New York City and for coordinating an international money-laundering scheme. Frank A. Tarentino III, Special Agent in Charge of the U.S. Drug Enforcement Administration’s (DEA) New...
Julio 18, 2022
PRESS RELEASE

Former Oregon Dentist Pleads Guilty in Federal Drug Case

Julio 13, 2022
PORTLAND, Ore.—A former Clackamas, Oregon dentist pleaded guilty today to illegally distributing controlled substances, including prescription drugs, and anabolic steroids. Salwan Wesam Adjaj, 43, a resident of West Linn, Oregon, waived indictment and pleaded guilty to a one-count information charging him with distributing and possessing with intent to distribute controlled...
Julio 13, 2022
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

Julio 12, 2022
ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
Julio 12, 2022
PRESS RELEASE

Collinsville Osteopathic Physician Admits Illegally Prescribing Drug

Julio 07, 2022
ST. LOUIS – An osteopathic physician from Collinsville, Illinois, pleaded guilty in U.S. District Court Tuesday and admitted illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, pleaded guilty in front of U.S. District Judge Ronnie L. White to one count of obtaining a controlled substance by fraud and one...
Julio 07, 2022
PRESS RELEASE

Robeson County Man Sentenced to 10 Years for Distributing Thousands of Illegal Pills While Possessing Gun

Julio 06, 2022
RALEIGH, N.C. – A Robeson County man was sentenced today to 120 months in prison for conspiracy to distribute and possessing with the intent to distribute thousands of illegal prescription pills including oxycodone, oxymorphone, hydrocodone, and methadone. On February 16, 2021, Jeffrey Randal Brooks, Jr., pleaded guilty to the charges...
Julio 06, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

Junio 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
Junio 28, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

Junio 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
Junio 28, 2022
Showing 221 - 230 of 414 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 19
  • Página 20
  • Página 21
  • Página 22
  • Current page 23
  • Página 24
  • Página 25
  • Página 26
  • Página 27
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster